欢迎您加入月均活跃用户100万+的科研社区!如您有任何系统建议,请点此洽谈。
;如有合作推广需求,请近期推荐: | 热 全流程投稿协助套餐服务 | 热 IF 3.0,JCR呼吸系统Q2期刊,正在征稿 | 热 IF2.6,科学、技术与医学跨学科期刊征稿中 |
![]() |
基本信息 | 登录收藏 | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字![]() | Drug Design Development and Therapy DRUG DES DEV THER (此期刊被最新的JCR期刊SCIE收录) LetPub评分 7.0
77人评分
我要评分
声誉 7.4 影响力 6.2 速度 8.8 | |||||||||||||||||||||||||||||||
期刊ISSN | 1177-8881 | ![]() 蝌蝌APP,让您与同行交流更轻松
![]() | ||||||||||||||||||||||||||||||
2024-2025最新影响因子 (数据来源于搜索引擎) | 5.1 点击查看影响因子趋势图 | |||||||||||||||||||||||||||||||
实时影响因子 | 截止2025年5月19日:5.143 | |||||||||||||||||||||||||||||||
2024-2025自引率 | 2.00%点击查看自引率趋势图 | |||||||||||||||||||||||||||||||
五年影响因子 | 5.2 | |||||||||||||||||||||||||||||||
JCI期刊引文指标 | 1.16 | |||||||||||||||||||||||||||||||
h-index | 48 | |||||||||||||||||||||||||||||||
CiteScore ( 2025年最新版) |
| |||||||||||||||||||||||||||||||
期刊简介 |
| |||||||||||||||||||||||||||||||
期刊官方网站 | https://www.dovepress.com/drug-design-development-and-therapy-journal | |||||||||||||||||||||||||||||||
期刊投稿格式模板 VIP专享 |
| |||||||||||||||||||||||||||||||
期刊投稿网址 | https://www.dovepress.com/submit_step_1.php | |||||||||||||||||||||||||||||||
期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Drug Design Development and Therapy的语言要求,还能让Drug Design Development and Therapy编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Drug Design Development and Therapy编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评(2篇) 论文致谢(2篇) 。
提交文稿 | |||||||||||||||||||||||||||||||
是否OA开放访问 | Yes | |||||||||||||||||||||||||||||||
OA期刊相关信息![]() | 文章处理费:需要( USD3300; ) 文章处理费豁免:查看说明 其他费用:没有 期刊主题关键词:drug design、drug safety、drug development、pharmaecuticals 相关链接:Aims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review | |||||||||||||||||||||||||||||||
通讯方式 | PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752 | |||||||||||||||||||||||||||||||
出版商 | Dove Medical Press Ltd. | |||||||||||||||||||||||||||||||
涉及的研究方向 | CHEMISTRY, MEDICINAL-PHARMACOLOGY & PHARMACY | |||||||||||||||||||||||||||||||
出版国家或地区 | ENGLAND | |||||||||||||||||||||||||||||||
出版语言 | English | |||||||||||||||||||||||||||||||
出版周期 | ||||||||||||||||||||||||||||||||
出版年份 | 2007 | |||||||||||||||||||||||||||||||
年文章数 | 403点击查看年文章数趋势图 | |||||||||||||||||||||||||||||||
Gold OA文章占比 | 99.58% | |||||||||||||||||||||||||||||||
研究类文章占比: 文章 ÷(文章 + 综述) | 79.90% | |||||||||||||||||||||||||||||||
WOS期刊JCR分区 ( 2024-2025年最新版) | WOS分区等级:1区
| |||||||||||||||||||||||||||||||
中国科学院《国际期刊预警 名单(试行)》名单 | 2025年03月发布的2025版:不在预警名单中 2024年02月发布的2024版:不在预警名单中 2023年01月发布的2023版:不在预警名单中 2021年12月发布的2021版:不在预警名单中 2020年12月发布的2020版:不在预警名单中 | |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2025年3月最新升级版) | 点击查看中国科学院期刊分区趋势图
| |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2023年12月升级版) |
| |||||||||||||||||||||||||||||||
中国科学院期刊分区 ( 2022年12月旧的升级版) |
| |||||||||||||||||||||||||||||||
SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1177-8881%5BISSN%5D | |||||||||||||||||||||||||||||||
平均审稿速度 | 网友分享经验: >12周,或约稿 | |||||||||||||||||||||||||||||||
平均录用比例 | 网友分享经验: | |||||||||||||||||||||||||||||||
版面费/APC文章处理费信息 | 文章处理费:需要( USD3300; ) 文章处理费豁免:查看说明 其他费用:没有 LetPub提供文章处理费(APC)支持服务,可以用人民币支付版面费啦! | |||||||||||||||||||||||||||||||
LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色,同行资深专家修改润色,SCI论文专业翻译,SCI论文格式排版,专业学术制图等)后论文在Drug Design Development and Therapy顺利发表。
快看看作者怎么说吧:服务好评(2篇) 论文致谢(2篇) 。 提交文稿 | |||||||||||||||||||||||||||||||
期刊常用信息链接 |
|
|
|
|
中国学者近期发表的论文 | |
1. | Mechanism of Action and Efficacy of Wu-Hua-Yan-Xiao in the Treatment of Pediatric Acute Pharyngitis Based on Network Pharmacology and Validation Author: Zhang, Xinyun; Zhang, Zengyu; Xu, Yingzi; Luo, Jiawei; Shen, Zihao; Liang, Hao; Zeng, Yidi; Liu, Wanghua; Zheng, Caixing; Li, Jinxia Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 4321-4342. DOI: 10.2147/DDDT.S513073 PubMed DOI |
2. | Research Trends and Developments in Nanomaterials for Rheumatoid Arthritis: A Comprehensive Bibliometric Analysis Author: Jia, Xuezhao; He, Lei; Chang, Yonglong; Li, Jiajie; Wang, Jing; Zhang, Xiaojun; Guo, Jinchen Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 4355-4371. DOI: 10.2147/DDDT.S514898 PubMed DOI |
3. | Comparison of the Dural Puncture Epidural and Conventional Epidural Analgesia Maintained Using Programmed Epidural Boluses for Labor Analgesia Author: Mo, Xiaofei; Yu, Jie; Qin, Zhimin; Ma, Junyi; Chen, Yueyue; Chen, Xi Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 4373-4382. DOI: 10.2147/DDDT.S521681 PubMed DOI |
4. | Simultaneous Determination of Unbound Plasma Concentration of Methotrexate and 7-Hydroxymethotrexate in Children Patients-Dose Methotrexate Author: Dong, Wei-Chong; Gao, Shuai-Shuai; Shi, Bo; Li, Hao-Ran; Jiang, Ye; Guo, Jia-Liang; Zhang, Zhi-Qing; Zhang, Ying-Ze Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 4383-4396. DOI: 10.2147/DDDT.S516431 PubMed DOI |
5. | Design and Synthesis of Novel 5,6,7,8-Tetrahydropyrido[2,3-D]pyrimidine Derivatives as VCP/p97 Inhibitors for the Treatment of Acute Myeloid Leukemia (AML) Author: Wang, Xueyuan; Long, Zebo; Wen, Tiantian; Miao, Hang; Ye, Xinran; Lei, Meng; Zhu, Yongqiang Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 4457-4479. DOI: 10.2147/DDDT.S509036 PubMed DOI |
6. | The Follicular Output Rate was Improved with 3-Day Letrozole Administration Compared with 5-Day Letrozole Administration Under Progestin-Primed Ovarian Stimulation Author: Wang, Xiaoning; Tian, Jiarong; Tian, Liu; Chen, Xin; Zhang, Zhenzhen; Diao, Honglu; Zhang, Ying Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 4397-4406. DOI: 10.2147/DDDT.S521554 PubMed DOI |
7. | Anemarrhena asphodeloides Bunge-Fritillaria Cirrhosae Bulbus Herb Pair Alleviates Ovalbumin-Induced Asthma by Regulating Arachidonic Acid Pathway Author: Tian, Xi; Cui, Qingfei; Wei, Jinhuan; Zhang, Qian; Zhang, Huiyi; Yang, Mengxin; Xing, Yiqi; Niu, Yukun; Li, Wenyu; Wang, Nan; Jin, Yiran; Du, Yingfeng Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 4407-4427. DOI: 10.2147/DDDT.S514891 PubMed DOI |
8. | Dolutegravir Derivatives Alleviate LPS-Induced Microglial Inflammation by Suppressing STAT1/3 Nuclear Translocation Author: Wang, Lan; Zhang, Xiaoting; Wang, Yimian; Mao, Longfei; Hou, Xixi; Peng, Lizeng Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 4567-4584. DOI: 10.2147/DDDT.S520724 PubMed DOI |
9. | Effects of Preoperative Magnesium Sulphate Infusion on Emergence Agitation and Postoperative Quality of Recovery in Patients Undergoing Thoracoscopic Lobectomy Author: Pu, Yutian; Geng, Xingyu; Wang, Maosan; Lv, Gaochao; Hu, Ziwei; Fang, Can; Zhang, Xinyue; Li, Wanting; Fan, Xiaoxuan; Chen, Xiuxia Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 4517-4525. DOI: 10.2147/DDDT.S503714 PubMed DOI |
10. | Comparison of Esketamine/Propofol and Sufentanil/Propofol on Intraoperative Hypoxemia During Bronchoscopy: A Randomized Trial Author: Huang, Xiao; Li, Xueyang; Sun, Yuan; Wu, Anshi; Ai, Pan Journal: DRUG DESIGN DEVELOPMENT AND THERAPY. 2025; Vol. 19, Issue , pp. 4429-4436. DOI: 10.2147/DDDT.S490423 PubMed DOI |
|
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2025 中国: LetPub上海 网站备案号:沪ICP备10217908号-1 沪公网安备号:31010402006960 (网站)31010405000484 (蝌蝌APP)
增值电信业务经营许可证:沪B2-20211595 网络文化经营许可证:沪网文[2023]2004-152号
礼翰商务信息咨询(上海)有限公司 办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室